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Alexithymia traits outweigh 
autism traits in the explanation 
of depression in adults with autism
Carola Bloch 1,2*, Lana Burghof1, Fritz‑Georg Lehnhardt1, Kai Vogeley1,3 & 
Christine Falter‑Wagner2,4
When contemplating the alarming depression rates in adults with autism spectrum disorder (ASD), 
there is a need to find factors explaining heightened symptoms of depression. Beyond the impact of 
autism traits, markedly increased levels of alexithymia traits should be considered as a candidate for 
explaining why individuals with ASD report higher levels of depressive symptoms. Here, we aim to 
identify the extent to which autism or alexithymia traits indicate depressive symptoms in ASD and 
whether the pattern of association are specific to ASD. Data of a large (N = 400) representative clinical 
population of adults referred to autism diagnostics have been investigated and split by cases with 
a confirmed ASD diagnosis (N = 281) and cases with a ruled out ASD diagnosis (N = 119). Dominance 
analysis revealed the alexithymia factor, difficulties in identifying feelings, as the strongest predictor 
for depressive symptomatology in ASD, outweighing autism traits and other alexithymia factors. 
This pattern of prediction was not specific to ASD and was shared by clinical controls from the referral 
population with a ruled out ASD diagnosis. Thus, the association of alexithymia traits with depression 
is not unique to ASD and may constitute a general psychopathological mechanism in clinical samples.
Autism traits and depression. Autism spectrum disorder (ASD) is characterized as a developmental 
disorder that entails pervasive peculiarities in communication and social interaction, as well as restricted and 
repetitive behavior, which exist as main diagnostic categories according to ICD-101. Depression remains a pre-
vailing comorbidity in ASD populations. A recent meta-analysis of 29 studies showed a heightened prevalence 
of current (23%) and lifetime (37%) depression in autistic  adults2. A subsequent question is whether traits that 
are inherent to autism suggest a cause for heightened depressive symptoms. It could be assumed that increased 
autism traits, such as social difficulties and behavioral maladaptation, constitute a possible loading factor. How-
ever, mixed empirical findings riddle the literature. For example, a longitudinal study found higher depression 
scores in children with autism ASD, and higher autism traits predicted higher depression rates in  adolescence3. 
In line with that, studies found positive correlations of autism traits with depression in non-clinical samples 
of  adults4–6 and a sample of adolescents and adults with  ASD7. Other studies reported no direct modulation of 
depressive symptoms by autism traits in adults with  ASD8–10. Thus, it remains unclear whether autism traits have 
a direct effect on depression that is not explained by other comorbidities in ASD.
Alexithymia traits and depression. Besides autism traits as a potential factor for depression in ASD, 
comorbid factors may account for heightened depressive symptoms. An increasingly discussed psychopatho-
logical construct, alexithymia, often co-occurs with ASD and is especially interesting in the context of depression 
in ASD. This condition was first described by  Sifneos11 and is also referred to as emotional blindness. In the gen-
eral population, the estimated prevalence of alexithymia is 10–20%12–16. In their recent meta-analysis, Kinnaird 
et al. reported a markedly increased prevalence of alexithymia in ASD of 50%17. Alexithymia measures usually 
comprise three different traits: Difficulties in Identifying Feelings (DIF), Difficulties Describing Feelings (DDF), 
and Externally-Oriented Thinking (EOT)18. Alexithymia has frequently been linked to  depression19–24. Regard-
ing the distinct alexithymia subdomains, a meta-analysis of studies found medium-sized effects of difficulties 
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identifying and describing feelings but only a weak relationship of externally-oriented thinking with self-reported 
 depression20.
Alexithymia traits, autism traits, and depression. Considering the high rates of alexithymia in ASD 
and an association of alexithymia with depression irrespective of ASD, it could be assumed that alexithymia 
traits modulate depression in ASD. By observing ASD and alexithymia as parallel factors for depression, Fietz 
and colleagues applied structural equation models on data from an online study addressed to participants from 
the general  population25. They showed that autism and alexithymia traits had medium-sized effects on depres-
sion. Morie and colleagues conducted an online questionnaire and investigated the effect of autism symptoma-
tology and alexithymia with depressive symptoms in adults with  ASD26. Their serial mediation analysis provides 
evidence that autism traits are not directly associated with depression. However, an indirect effect was found, 
which indicated that autism traits could lead to enhanced depressive symptoms through a positive association 
with alexithymia and weaker emotion regulation  abilities26. The validity and generalizability of this online study 
is limited as the small sample consisted primarily of females (47*f/17*m), and diagnoses were not confirmed by 
any clinical  assessment26. Furthermore, the association with depression of both autism and alexithymia raises 
questions concerning the interpretability of many previous studies testing only one of these predictors or both 
without controlling their covariation. To date, no study has tested the potentially different effects of alexithymia 
traits (DIF, DDF, EOT) on depression in a clinical population of individuals with and without ASD, allowing for 
judgments of specificity.
Consequently, the aims of the current study are to (a) clarify whether autism traits or alexithymia traits better 
explain depressive symptoms in adults with ASD, (b) establish whether there is a differential predictive power of 
the three alexithymia traits, and (c) determine whether such predictive associations with depression are specific 
to ASD. For this purpose, we analyzed data of a representative clinical population of adults referred to outpatient 
clinics for autism diagnostics. Groups were split into cases with a confirmed ASD diagnosis (N = 281) and cases 
with a ruled out ASD diagnosis (N = 119), allowing for direct clinical comparison and statistically accounting for 
the strong association between autism and alexithymia traits by employing dominance  analysis27.
Method
Participants. Participant characteristics are reported in Table 1. The data analyzed in this study are based 
on post-hoc naturalistic and comprehensive sampling from the referral population in the outpatient clinic for 
autism in adulthood at the University Hospital Cologne. Data was collected from 2006 until 2019. The project 
has been approved by the ethical commission of the medical faculty of the University of Cologne (case number: 
20-1432). Data analyzed in this study was fully anonymized. The need to obtain informed consent from the 
subjects included in this retrospective study has been declared dispensable by the ethics committee of the medi-
cal faculty of the University of Cologne. According to §6 para. 1 sentence 1 GDSG NRW (‘Gesundheitsdaten-
schutzgesetz Nordrhein-Westfalen’) academic staff is allowed to make scientific use of data to which they have 
access because of their activities, without the consent of the persons concerned being necessary. Individuals were 
referred to the outpatient clinic for ASD by medical consultants based on suspicion of a possible ASD diagnosis 
due to reported social-emotional symptoms. Diagnostic procedures throughout the period of data collection 
were conducted in accordance with German guidelines for the diagnosis of ASD in  adulthood28, comprising 
neuropsychological testing and clinical assessment of at least two independent clinicians and a clinical consen-
sus decision. An ASD diagnosis was given if patients met all diagnostic criteria of ICD-101.
The comprehensive clinical population was split into ASD+ cases (N = 281), consisting of individuals who 
received a diagnosis of F84.5 (n = 242; Asperger Syndrome), F84.1 (n = 18; Atypical Autism), or F84.0 (n = 21; 
Childhood Autism) according to ICD-101, and cases consisting of individuals for whom any F84 diagnosis was 
ruled out, hence referred to as ASD− (N = 119). Thus, the ASD− group comprises individuals who exhibited social 
difficulties but specifically did not fulfill the criteria for an ASD diagnosis. Patients who received a diagnosis of 
F84.8 (n = 21, other pervasive developmental disorders) or F84.9 (n = 50, pervasive developmental disorder—not 
otherwise specified, PDD-NOS) were not included in the analyzes because of the ambiguity of group assignment.
Table 1.  Characteristics of both diagnostic samples: confirmed (ASD+) and ruled out (ASD−) diagnosis 
of ASD. Number and percentage of males and females in groups with results of Pearson’s chi-square test for 
frequency distribution in groups. Means (M) with standard deviations (SD) for metric variables with results of 
t-test (two-tailed, α = .05) for independent groups [Levene tests confirmed equal variances (p > 0.05)].
Variable ASD+ ASD−
n % n % χ2 df p
Male 219 78 81 68
Female 62 22 38 32 3.832 1 0.050
M SD M SD t(398) p d
Age 33.2 11.0 33.5 12.5 0.253 0.801 0.057
IQ 104.3 16.6 100.7 14.7  − 2.055 0.041  − 0.212
PIQ 99.7 16.3 98.0 14.1  − 1.040 0.299  − 0.107
VIQ 107.0 16.4 101.8 15.2  − 2.942 0.003  − 0.314
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Further inclusion criteria were total IQ scores > 70, measured with the German version of the Wechsler Adult 
Intelligence Scale (WIE-III) which includes measures of performance-based IQ (PIQ) and verbal IQ (VIQ)29, and 
less than four missing items on the Autism-Spectrum Quotient (AQ)30 and the 20-Item Toronto Alexithymia Scale 
(TAS-20)18. In total, n = 19 (ASD+) and n = 12 (ASD−) had one missing item, n = 5 (ASD+) and n = 5 (ASD−) had 
two missing items, and n = 2 (ASD+) had three missing AQ items. For TAS-20, n = 8 (ASD+) and n = 4 (ASD−) 
had one missing item, n = 2 (ASD+) had two missing items, and n = 1 (ASD+) had three missing items. Missing 
items were replaced by group means. One ASD+ case was not included in the analysis due to an extremely low 
outlier score on the AQ (< 3 SD from M).
Retrieved data. Depressive symptoms were assessed with the German version of the Beck Depression Inven-
tory (BDI)31. BDI is a self-report questionnaire that assesses depressive symptoms over 21  items32. Each item was 
answered on a four-point scale, scoring from 0–3, with higher scores indicating increased symptom severity. 
Scores in the range of 11–17 indicate mild to moderate depressive symptoms and scores ≥ 18 classify clinically 
relevant  depression31. In the ASD+ and ASD− groups, 25.27% and 20.17% of cases reported mild-moderate 
symptoms, respectively. In the ASD+ and ASD− groups, 30.60% and 41.18% reported clinically relevant depres-
sive symptoms, respectively.
The AQ is a well-established 50-item self-report questionnaire assessing autism traits including social skills, 
difficulties in attention switching, the degree of attention to detail, and difficulties in communication and imagina-
tion30. Each of the 50 items was answered on a Likert-scale, ranging from 1 = agree to 4 = disagree and re-coded 
to 1 or 0 for summing. Scores > 32 depict pronounced autism  traits30. In the ASD+ and ASD− groups, 83.63% 
and 78.15% of cases reported autism traits above this threshold, respectively. The internal consistency of the 
scale was good (α = 0.86).
The TAS-20 is a self-report questionnaire assessing alexithymia on three dimensions (DIF, DDF, and EOT)18. 
Each item was answered on a five-point Likert-scale, ranging from 5 = strongly agree to 1 = strongly disagree. The 
recommended cut-off for clinically relevant alexithymia is  6133. In the ASD+ and the ASD− samples, 66.19% and 
68.91% reported clinically relevant alexithymia traits, respectively. Cronbach’s alphas for all subscales revealed 
good internal consistencies for DIF (α = 0.85) and DDF (α = 0.74) and acceptable internal consistency for EOT 
(α = 0.60).
Statistical procedures. Data preprocessing and analysis were conducted in  RStudio34 using the statistical 
programming language  R35. Based on their extensive taxometric analysis, Parker et al. argued that the latent 
structure of alexithymia should be considered continuous rather than  categorical36. Accordingly, we analyzed 
alexithymia traits based on metric scales. Two sample t-tests were conducted to compare ASD+ and ASD− in 
terms of TAS-20, AQ, and BDI. Pearson zero-order correlations measures of interest were calculated with Bon-
ferroni adjustment (Table  2). For multivariate analysis, regression models were calculated with autism traits 
(AQ) and alexithymia traits (DIF, DDF, EOT) as predictors of self-reported depressive symptoms (BDI) in 
ASD+ and ASD− samples. The samples differed significantly in IQ scores, with higher scores in the ASD+ sample 
(t(398) =  − 2.055, p < 0.05, d =  − 0.212), driven by higher scores in VIQ (t(398) =  − 2.942, p < 0.05, d =  − 0.314). 
We included age, sex, and measures of PIQ, and VIQ as control variables to account for potential confounds (see 
Table 1 for summary statistics and significance tests). The model for the ASD− sample met all assumptions for 
general linear models; namely, sample sizes were sufficient for the number of predictors, adequate model fit (< 5% 
of standardized residuals > 2), independence of errors (Durbin–Watson statistic ≈ 2), lack of multicollinearity 
(variance inflation factor < 2 for all predictors in all models), and homoscedasticity for the ASD− model. As for 
the model of the ASD+ sample, heteroscedasticity was implied by funneled residual plots and a significant result 
in the Breusch Pagan Test, robust regression with heteroscedasticity-consistent covariance matrix (HCCM) was 
conducted, using the sandwich37 and lmtest38 packages in R. HCCMs were retrieved by the vcovHC() function, 
applying the HC3 method based on recommendations by Long &  Ervin39. HCCM was proposed as an adequate 
method for adjustment of errors in case of heteroscedasticity by Rosopa et al.40.
Table 2.  Descriptive statistics and correlations for variables of interest. Pearson’s product moment correlation 
coefficients (p values, Bonferroni-adjusted).
Variable Sample M SD BDI AQ DIF DDF
BDI
ASD+ 13.9 10.4 –
ASD− 15.7 10.5
AQ
ASD+ 38.7 6.1 0.25 (0.000) –
ASD− 37.6 5.8 0.20 (0.033)
DIF
ASD+ 22.1 6.1 0.41 (0.000) 0.52 (.000) –
ASD− 23.2 6.6 0.25 (0.006) 0.44 (0.000)
DDF
ASD+ 19.1 3.8 0.26 (0.000) 0.47 (0.000) 0.59 (0.000) –
ASD− 18.9 4.0  − 0.01 (0.877) 0.40 (0.000) 0.61 (0.000)
EOT
ASD+ 23.4 5.2  − 0.03 (0.650)  − 0.01 (0.827) 0.08 (0.203) 0.22 (0.000)
ASD− 23.7 5.1 0.05 (0.551) 0.00 (0.952)  − 0.01 (0.923) 0.17 (0.065)
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Correlations of autism and alexithymia traits could have problematic results when interpreting their relative 
effects through beta coefficients. Beta coefficients represent the total effects, whereas general dominance weights 
(GDW) constitute a global index of importance. This was suggested as a new comparison standard for multiple 
regression because it considers direct, total, and partial  effects27. This method was previously introduced regard-
ing the inference of linear effects of alexithymia and ASD on  empathy41. GDWs were an adequate and easily 
interpretable effect size for answering the research questions concerning the relative effects of alexithymia and 
autism traits in our analysis. GDWs were calculated with their bootstrapped 95% confidence intervals (100 resa-
mples) using the yhat package in  R42. GDWs were retrieved by dominance  analysis43, in which unique variance 
explained by each predictor was calculated by the squared semipartial correlation averaged across all models in 
all possible subsets that included that  predictor27. GDWs together sum up to the total determination factor R2 
of the model. Therefore, they allowed for the calculation of the relative proportion of each predictor in variance 
explanation and, thus, the ranking of predictors within the  models44.
Results
Table 2 depicts mean scores and correlations of the measures of interest in the groups. The ASD+ sample did not 
significantly differ from the ASD− sample in any TAS-20 subdomains, DIF (t(398) = 1.698, p = 0.090, d = 0.186), 
DDF (t(398) =  − 0.555, p = 0.579, d =  − 0.061), and EOT (t(398) = 0.488, p = 0.626, d = 0.053). The groups did 
not differ significantly in their levels of AQ (t(398) =  − 1.693, p = 0.091, d =  − 0.185) and BDI (t(398) = 1.579, 
p = 0.115, d = 0.173).
Regarding correlations with depressive symptoms in the ASD + sample, BDI scores significantly increased 
with AQ (r = 0.25, p < 0.001, 95% CI [0.13, 0.35]), DIF (r = 0.41, p < 0.001, 95% CI [0.31, 0.51]), and DDF (r = 0.26, 
p < 0.001, 95% CI [0.15, 0.37]), but not with EOT (r =  − 0.03, p = 0.650, 95% CI [ − 0.14, 0.09]). In the ASD− sam-
ple, BDI significantly increased with AQ (r = 0.20, p =  < 0.05, 95% CI [0.02, 0.36]), and with DIF (r = 0.25, p < 0.05, 
95% CI [0.08, 0.41]), but not with DDF (r =  − 0.01, p < 0.877, 95% CI [ − 0.19, 0.16]) or EOT (r = 0.05, p = 0.551, 
95% CI [ − 0.13, 0.23]). Considering correlations of autism and alexithymia traits in the ASD + sample, DIF sig-
nificantly increased with AQ (r = 0.52, p < 0.001, 95% CI [0.42, 0.60]) and DDF (r = 0.47, p < 0.001, 95% CI [0.37, 
0.56]). Similarly, AQ significantly increased with DIF (r = 0.44, p < 0.001, 95% CI [0.28, 0.58]) and DDF (r = 0.40, 
p < 0.001, 95% CI [0.24, 0.54]) in the ASD− sample. EOT was not correlated with AQ in either sample (ASD + : 
r =  − 0.01, p = 0.827, 95% CI [ − 0.12, 0.10]/ASD−: r = 0.00, p = 0.952, 95% CI [ − 0.18, 0.18]).
Table 3 depicts regression estimates and results of dominance analysis with BDI as the dependent variable. The 
model in the ASD + sample explained 23.2% variance in BDI score (F(8,272) = 10.27, p < 0.001). GDW estimates 
of AQ, DIF, DDF, and EOT allowed for ranking predictors in terms of importance by their proportion of variance 
explanation (R2). In the ASD + sample, DIF stood out as the strongest predictor (GDW = 0.116, CI [0.062, 0.173], 
50.0% of R2), DDF was the second (GDW = 0.029, CI [0.014, 0.059], 12.5% of R2), and AQ the third strongest 
predictor (GDW = 0.020, CI [0.009, 0.049], 8.6% of R2) with negative coefficients. This indicates that autism traits 
did not affect depression beyond alexithymia traits. The model in the ASD− sample explained 18.3% variance of 
BDI scores (F(8,110) = 3.08, p < 0.01). Estimates revealed a similar structure as the ASD + sample: DIF was the 
strongest predictor (GDW = 0.068, CI [0.012, 0.144], 37.1% of R2), DDF was ranked second (GDW = 0.024, CI 
[0.005, 0.114], 13.1% of R2), and AQ third (GDW = 0.019, CI [0.002, 0.078], 10.4% of R2). EOT was the weakest 
predictor of depressive symptoms with small effect sizes in the ASD+ sample (GDW = 0.003, CI [0.001, 0.037], 
1.3% of R2) and in the ASD− sample (GDW = 0.002, CI [0.001, 0.049], 1.1% of R2).
Discussion
The key findings of the current study are:
(a) Alexithymia traits (i.e. DIF & DDF) outweigh autism traits in the multivariate prediction of depressive 
symptoms in adults with ASD,
Table 3.  Models with BDI as dependent variable. Models for ASD+ (N = 281) and ASD− (N = 119) samples. 
Standardized regression coefficients (β) with standard errors (SE) or HCCM-adjusted errors (SEadj). General 
dominance weights (GDW) retrieved by dominance analysis with lower limits (LL) and upper limits (UL) of 
bootstrapped confidence intervals. Strongest predictor in each model in bold.
Predictors
ASD+ ASD−
β SEadj GDW LL, UL β SE GDW LL, UL
Age 0.184 0.061 0.042 0.007, 0.094 0.013 0.079 0.003 0.001, 0.042
Sex 0.147 1.294 0.016 0.003, 0.044 0.164 2.067 0.015 0.001, 0.085
PIQ 0.030 0.043 0.004 0.001, 0.020  − 0.061 0.080 0.020 0.002, 0.080
VIQ  − 0.038 0.045 0.002 0.001, 0.015  − 0.199 0.077 0.032 0.004, 0.121
AQ  − 0.006 0.137 0.020 0.009, 0.049 0.195 0.199 0.019 0.002, 0.078
DIF 0.369 0.136 0.116 0.062, 0.173 0.354 0.187 0.068 0.012, 0.144
DDF 0.064 0.194 0.029 0.014, 0.059  − 0.302 0.313 0.024 0.005, 0.114
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(b) The alexithymia trait, difficulties identifying feelings, is the strongest predictor of depressive symptom sever-
ity, and
(c) Similar patterns of prediction in both models, for adults with and without ASD, imply a general mechanism 
for depression in clinical samples.
Autism traits significantly correlated with depressive symptoms, which is in line with studies that also reported 
positive  correlations4–7. Nevertheless, considering the high correlation of alexithymia and autism traits, our 
multivariate analysis puts this association in a new perspective because autism traits were only ranked third after 
alexithymia traits difficulties identifying feelings and difficulties describing feelings. This aligns with past studies, 
particularly with the findings of Morie et al.26, as they resemble the direct effect of alexithymia on depressive 
symptoms in adults with ASD. Beyond replication, our results imply difficulties identifying feelings as the main 
factor in predicting depressive symptom severity. Furthermore, the effect of difficulties identifying feelings is 
in accordance with Li et al. who reported an overall medium effect size in their meta-analysis of studies from 
the general population and depression  patients20. Li et al. further reported medium effect sizes for difficulties 
describing feelings on depression, whereas we found only small effect sizes in the multivariate observation. As 
univariate correlations revealed a positive correlation with self-reported depressive symptoms, the small effect 
in the dominance analysis could hint at an intersection of variance explanation with autism traits. As AQ already 
includes communication difficulties, it may act as a suppressor for the scale assessing difficulties describing feelings.
Importantly, we need to understand whether prediction patterns of depression are unique to ASD for clinical 
decision making with respect to treatment planning. We found depressive symptoms to be similarly modulated 
by alexithymia traits and specifically explained by difficulties identifying feelings in a clinical population with a 
ruled out ASD diagnosis. Hence, alexithymia, in general, and difficulties identifying feelings, in particular, might 
be generally associated with depression requiring attention in treatment planning beyond ASD.
There are some important methodological and theoretical implications of this study. First, our results sup-
port the suggestion that the alexithymia subdomains should be considered individually to make inferences 
about distinct and subtle  effects20,24,45. As the subdomains showed different temporal  stability24, dissimilar 
internal  consistencies13,33,46, may distinctively relate to measures of psychological  stress47, and are semantically 
 different20,45. Thus, observations of individual subdomains should be standard. Subdomain splitting makes sense 
with regard to the different extent of social characteristics comprising the subdomains, especially in the context 
of ASD. While difficulties in identifying feelings and externally-oriented thinking are person-level domains, difficul-
ties describing feelings represents a social domain of alexithymia. Thus, for individuals with pronounced autism 
traits comprising social communication difficulties, high scores in this domain might reflect a trend of social 
withdrawal rather than a cause of malfunctioning emotional access.
Another important aspect of our study is the replication of prior results that showed high correlations of 
autism and alexithymia  traits41,48. We encourage future research to consider this finding in their methodologi-
cal procedures. For relative effects in the case of covariation of predictors, dominance weights demonstrate a 
reasonable alternative to beta coefficients as they represent a valid and easily interpretable estimate of relative 
importance of each  predictor27,44.
It has been suggested by different authors that alexithymia could be used to define subgroups within the 
autism  spectrum12,49. Based on our results, we would tentatively agree but additionally argue that alexithymia 
should be regarded in terms of subdomains and as continuous  variables36. Our results demonstrate that a sub-
group of adults with ASD can be described by high levels of difficulties identifying feelings, and this subgroup may 
specifically profit from interventions that target emotional regulation abilities and foster introspection. Regarding 
this potential subgroup in ASD, it could be assumed that heightened rates of difficulties identifying feelings have 
their origin outside autism features. Szatmari et al. found that parents of children with ASD reported significantly 
higher degrees of difficulties identifying feelings compared to parents of children with Prader Willi  syndrome50. 
This result was recently replicated with the addition that difficulties identifying feelings were associated with 
depression in mothers and fathers of children with  ASD51. As studies showed that alexithymia is potentially 
passed on to children through  heredity52 and family  interactions53, it could be suggested that heightened rates of 
difficulties in identifying feelings in a subgroup could be explained by external factors (family or affiliated persons). 
Likewise, it could be suggested that autism traits are potentially heightened within the family, which gives rise to 
alexithymia. Etiological pathways remain unclear, and future studies should be conducted that specifically target 
alexithymia in individuals with ASD and their caregivers in a longitudinal design. Such research could better 
inform the possible origins of pronounced alexithymia traits in ASD and allow for inference of alexithymia as a 
cause for, or consequence of, depression in ASD.
Aside from the methodological advantages and important implications, the current study has limitations. 
First of all, we applied a retrospective cross-sectional design that does not allow for causal inference. Questions 
about the directionality of effects and etiological pathways remain a target for future prospective longitudinal 
studies. Additionally, our results are based on post-hoc naturalistic and comprehensive sampling from the refer-
ral population in two outpatient clinics for adults with autism. While this approach has the asset of delivering 
directly translatable generalization into the clinical reality of adult outpatient clinics, the clinical comparison 
group of individuals with suspicion of, but ultimately ruled-out, ASD diagnosis results in a heterogeneous clinical 
sample. Future studies will need to add to the question of generalizability by testing homogeneous clinical samples 
characterized by, for instance, social phobia. Another limitation that should be considered is that all measures 
were retrieved via self-report. Deploying questionnaires for all measures potentially results in variance that is 
only due to this common method. Future studies should include various methods to compensate for this bias.
By deploying adequate methods for inference about the differential predictive power of alexithymia and 
autism traits in a large representative referral population for autism diagnostics in adulthood, the current results 
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suggest that the alexithymia trait, difficulties identifying feelings, acts as a major predictor for depression in 
adults with ASD. Our results further show that this effect is not specific to ASD and potentially reflects a general 
mechanism in clinical samples.
Additional information
The use of language in this article was chosen based on suggestions in: Tepest, R. (2020). The meaning of diag-
nosis for different designations in talking about autism. Journal of Autism and Development. (DOI: https ://doi.
org/10.1007/s1080 3-020-04584 -3).
Data availability
The aggregated data analyzed during the current study and the R Script used for analysis are available from the 
corresponding author on reasonable request.
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